These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9802616)

  • 1. Genomic organization of the canine p53 gene and its mutational status in canine mammary neoplasia.
    Chu LL; Rutteman GR; Kong JM; Ghahremani M; Schmeing M; Misdorp W; van Garderen E; Pelletier J
    Breast Cancer Res Treat; 1998 Jul; 50(1):11-25. PubMed ID: 9802616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P53 mutations in mammary tumor cell lines and corresponding tumor tissues in the dog.
    Van Leeuwen IS; Hellmèn E; Cornelisse CJ; Van den Burgh B; Rutteman GR
    Anticancer Res; 1996; 16(6B):3737-44. PubMed ID: 9042250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations of p53 tumor suppressor gene in spontaneous canine mammary tumors.
    Lee CH; Kweon OK
    J Vet Sci; 2002 Dec; 3(4):321-5. PubMed ID: 12819382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 gene mutations occurring in spontaneous benign and malignant mammary tumors of the dog.
    Muto T; Wakui S; Takahashi H; Maekawa S; Masaoka T; Ushigome S; Furusato M
    Vet Pathol; 2000 May; 37(3):248-53. PubMed ID: 10810989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic status of p53 gene mutation in canine mammary carcinoma.
    Wakui S; Muto T; Yokoo K; Yokoo R; Takahashi H; Masaoka T; Hano H; Furusato M
    Anticancer Res; 2001; 21(1B):611-6. PubMed ID: 11299814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel canine tumour suppressor gene p53 mutations in cases of skin and mammary neoplasms.
    Mayr B; Reifinger M; Alton K
    Vet Res Commun; 1999 Aug; 23(5):285-91. PubMed ID: 10493115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrations of the p53 tumor suppressor gene in various tumors in dogs.
    Setoguchi A; Sakai T; Okuda M; Minehata K; Yazawa M; Ishizaka T; Watari T; Nishimura R; Sasaki N; Hasegawa A; Tsujimoto H
    Am J Vet Res; 2001 Mar; 62(3):433-9. PubMed ID: 11277210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of tumour-associated and germ line p53 mutations in canine mammary cancer.
    Veldhoen N; Watterson J; Brash M; Milner J
    Br J Cancer; 1999 Oct; 81(3):409-15. PubMed ID: 10507764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.
    Hietanen SH; Kurvinen K; Syrjänen K; Grénman S; Carey T; McClatchey K; Syrjänen S
    Am J Obstet Gynecol; 1995 Nov; 173(5):1477-82. PubMed ID: 7503188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development.
    Jerry DJ; Ozbun MA; Kittrell FS; Lane DP; Medina D; Butel JS
    Cancer Res; 1993 Jul; 53(14):3374-81. PubMed ID: 8324748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of hyperamplification of centrosomes in naturally developing tumors of dogs.
    Setoguchi A; Okuda M; Nishida E; Yazawa M; Ishizaka T; Hong SH; Hisasue M; Nishimura R; Sasaki N; Yoshikawa Y; Masuda K; Ohno K; Tsujimoto H
    Am J Vet Res; 2001 Jul; 62(7):1134-41. PubMed ID: 11453492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.
    Kannan K; Krishnamurthy J; Feng J; Nakajima T; Tsuchida N; Shanmugam G
    Int J Oncol; 2000 Nov; 17(5):1031-5. PubMed ID: 11029509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis of three tumor suppressor genes in two models of rat hepatocarcinogenesis.
    Gómez-Angelats M; Teeguarden JG; Dragan YP; Pitot HC
    Mol Carcinog; 1999 Jul; 25(3):157-63. PubMed ID: 10411141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis.
    Tamura G; Kihana T; Nomura K; Terada M; Sugimura T; Hirohashi S
    Cancer Res; 1991 Jun; 51(11):3056-8. PubMed ID: 2032245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 abnormalities in primary prostate cancer: single-strand conformation polymorphism analysis of complementary DNA in comparison with genomic DNA. The Cooperative Prostate Network.
    Gumerlock PH; Chi SG; Shi XB; Voeller HJ; Jacobson JW; Gelmann EP; deVere White RW
    J Natl Cancer Inst; 1997 Jan; 89(1):66-71. PubMed ID: 8978408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic alterations in eight mammary tumors and tumor-suppressor gene p53 mutation in one mammary tumor from dogs.
    Mayr B; Dressler A; Reifinger M; Feil C
    Am J Vet Res; 1998 Jan; 59(1):69-78. PubMed ID: 9442248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LOH and mutational analysis of p53 alleles in mouse urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl) nitrosamine.
    Morimura K; Yamamoto S; Murai T; Mori S; Chen TX; Wanibuchi H; Fukushima S
    Carcinogenesis; 1999 Apr; 20(4):715-8. PubMed ID: 10223204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymerase chain reaction-based approaches for detection of allelic loss in the p53 tumor suppressor gene in colon neoplasms.
    Yamaguchi K; Sugano K; Fukayama N; Nakashima Y; Saotome K; Yokoyama T; Yokota T; Ohkura H
    Am J Gastroenterol; 1997 Feb; 92(2):307-12. PubMed ID: 9040212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of p53 gene mutations in human ovarian and endometrial cancers by polymerase chain reaction-single strand conformation polymorphism analysis.
    Naito M; Satake M; Sakai E; Hirano Y; Tsuchida N; Kanzaki H; Ito Y; Mori T
    Jpn J Cancer Res; 1992 Oct; 83(10):1030-6. PubMed ID: 1333465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.